Why EDAP TMS S.A.’s (FOCL) Stock Is Up 5.14%
As of Tuesday, August 25, EDAP TMS S.A.’s FOCL share price has surged by 5.14%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. It also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. In addition, the company manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters; and sells spare parts and disposables, such as electrodes. Further, it markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. The company has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France.
Commentary & Analysis
Why EDAP TMS S.A.’s (FOCL) Stock Is Down 5.50%
As of Tuesday, August 18, EDAP TMS S.A.’s FOCL share price has dipped by 5.50%, which has investors questioning if this is right time to buy.Michael Rose
What You Need to Know About EDAP TMS S.A.'s Q3 Earnings
EDAP TMS S.A.'s fiscal Q3 earnings report was released on Thursday, August 13. Let's dive in to see if (FOCL) missed or beat analyst's expectations.Michael Rose
Why EDAP TMS S.A.’s (FOCL) Stock Is Down 16.89%
As of Wednesday, August 12, EDAP TMS S.A.’s FOCL share price has dipped by 16.89%, which has investors questioning if this is right time to buy.Michael Rose
Why EDAP TMS S.A.’s (FOCL) Stock Is Down 17.39%
As of Wednesday, August 12, EDAP TMS S.A.’s FOCL share price has dipped by 17.39%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Financial Summary
| Share Statistics | FOCL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $190.7 | $423.0 | 26% |
|
| Shares Out (Mil) | 37.5 | 41.5 | 41% |
|
| Institutional Ownership | 76.3% | 83.6% | 46% |
|
| Float (Mil) | 36.3 | 35.5 | 40% |
|
| Beta | -0.03 | 0.88 | 6% |
|
| Avg Daily Volume (000s) | 69 | 346 | 32% |
|
| Price Change (52-week) |
64.7% | 65.4% | 85% |
|
| Growth | FOCL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 6.7% | 11.8% | 44% |
|
| Net Income (5yr) | (69.3%) | (5.8%) | 4% |
|
| EPS (5yr) | (60.6%) | 10.4% | 2 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (33.0%) | (15.5%) | 17% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 3 | |
| Current EPS | ($0.260) | ($1.040) | ($0.667) | |
| Month Ago EPS | ($0.215) | ($0.815) | ($0.605) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.220) | ($0.805) | ($0.620) | |
| Year/Year Chg | (32.3%) | 33.2% | (44.9%) | |
| Financials | FOCL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $79 | $119 | 24% |
|
| Net Income (TTM) (Mil) | ($39) | ($9) | 18% |
|
| EPS (TTM) | ($1.040) | ($0.400) | 21% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | ($3) | 18% |
|
| Net Cash Flow (TTM) (Mil) | $8 | $1 | 54% |
|
| Long-Term Debt (Q1) (Mil) | $38 | $23 | 37% |
|
| Enterprise Value (Q1) (Mil) | $210 | $376 | 26% |
|
| Valuation | FOCL | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.85 | na |
|
| P/E | na | 27.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.6 | na |
|
| Ratios | FOCL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 44.5% | 58.5% | 55% |
|
| Net Margin | (49.1%) | (6.9%) | 12% |
|
| ROA | (50.1%) | (13.3%) | 12% |
|
| ROE | (229.1%) | (13.3%) | 4% |
|
| Liabilities to Assets | 104.3% | 46.0% | 95% |
|
| F-Score | 2 | 4 | 7% |
|
EDAP TMS S.A. did not pass any screens on 9/4/2026.
